Dow Up 0.11% Nasdaq Up 0.50%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NMS
69.67 Up 1.21(1.77%) 4:00PM EDT
|After Hours : 70.02 Up 0.35 (0.50%) 7:09PM EDT
Prev Close:68.46
Open:68.68
Bid:56.00 x 100
Ask:70.02 x 100
1y Target Est:100.60
Beta:2.31
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:67.69 - 70.08
52wk Range:47.03 - 112.57
Volume:368,404
Avg Vol (3m):704,438
Market Cap:5.32B
P/E (ttm):N/A
EPS (ttm):-5.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALNY

Comparison

Symbol% ChgMkt Cap
ALNYUp 1.77%5.32B
MRKUp 0.18%173.40B
PFEUp 0.03%186.36B
VRXUp 0.38%39.34B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):147.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-5.37
Quarterly EPS Est (Sep-14) :-0.62
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.84

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback